- Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
- Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
- Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
- Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。
Found 4 Reference Ions Near m/z 659.5242
NovoCell ID | m/z | Mass Window | Metabolite | Ranking | Anatomy Context |
---|---|---|---|---|---|
MSI_000043213 Reliable | 659.5145 | 659.5142 ~ 659.5147 MzDiff: 2.0 ppm |
Acidissiminin (BioDeep_00000035657) Formula: C43H65NO4 (659.4913) |
6.06 (76%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000043877 Reliable | 659.5146 | 659.5146 ~ 659.5146 MzDiff: 0.1 ppm |
DG(18:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) (BioDeep_00000220902) Formula: C41H70O6 (658.5172) |
1.92 (67%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000045846 Reliable | 659.5146 | 659.5146 ~ 659.5146 MzDiff: 0.1 ppm |
DG(18:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) (BioDeep_00000220902) Formula: C41H70O6 (658.5172) |
1.92 (67%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000055920 Unavailable | 659.5151 | 659.5151 ~ 659.5151 MzDiff: none |
Acidissiminin (BioDeep_00000035657) Formula: C43H65NO4 (659.4913) |
-0.36 (100%) | Homo sapiens [UBERON:0007779] transudate |
Found 2 Sample Hits
Metabolite | Species | Sample | |
---|---|---|---|
Soyasapogenol B 24-O-b-D-glucoside Formula: C36H60O8 (620.4288) Adducts: [M+K]+ (Ppm: 3.6) |
Homo sapiens (colorectal adenocarcinoma) |
520TopL, 490TopR, 510BottomL, 500BottomR-profileResolution: 17μm, 147x131
The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024). |
|
m/z_659.5218 Formula: - (n/a) Adducts: (Ppm: 0) |
Homo sapiens (colorectal adenocarcinoma) |
439TopL, 409TopR, 429BottomL, 419BottomR-profileResolution: 17μm, 157x136
The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024). |
|